Stabilized transient gene expression
AssigneeGenespan Corporation
InventorsRandal A. Goffe, Adeelia S. Goffe
Life of this patent
Estimating the term…
Abstract
This invention provides methods and chemical agents for enhancing transient expression in eukaryotic cells. Also provided are a model system for achieving prolonged transient expression in solid tumors, a means for culturing hepatocytes without feeder cells or an extracellular matrix bonded to the substratum, a method for manipulating cellular metabolism to reduce the consumption of glucose and a means for inducing the secretion of an endogenous phosphatase activity.
Claims37
A method of enhancing the transient expression of a foreign gene in a eukaryotic cell in vitro comprising:
- introducing into the cell a molecule of foreign DNA that encodes a protein in a form capable of being expressed in the cell;
- contacting the cell before, during, or after introducing the DNA with a biocompatible transient expression enhancing agent, provided that said agent is not butyrate or butyric acid;
- maintaining the cell in a non-selective medium after introducing the DNA;
- and,
- detecting the foreign protein in the cell after maintaining the cell for at least five days to the non-selective medium.
A method of enhancing the transient expression of a foreign gene in a eukaryotic cell in vitro comprising:
- introducing into the cell a molecule of foreign DNA that encodes a protein in a form capable of being expressed in the cell;
- contacting the cell with a first agent during the introduction into the cell of the foreign DNA, wherein the agent comprises at least one compound having the formula:
- ##STR4## wherein R.sub.1 is:
- CHNH.sub.2 R.sub.3, wherein R.sub.3 is the side chain of a naturally occurring amino acid;
- C.sub.6 H.sub.4 R.sub.4, wherein R.sub.4 is H, CH.sub.3, (CH.sub.2).sub.n CH.sub.3, NH.sub.2, COCH.sub.3, CO(CH.sub.2).sub.n CH.sub.3, C(CH.sub.3).sub.3, CH(CH.sub.3).sub.2, (CH.sub.2).sub.n CH(CH.sub.3).sub.2, (CH.sub.2).sub.n COCH.sub.3, OCH.sub.3, or O(CH.sub.2).sub.n CH.sub.3, wherein n=1-3;
- CHNH.sub.2 (CH.sub.2).sub.n R.sub.5, wherein n=1-7 and R.sub.5 is CH.sub.3, OH, CONH.sub.2, C.sub.6 H.sub.4 OH, or CONHNH.sub.2 ;
- (CH.sub.2).sub.n R.sub.6, wherein n=1-9 and R.sub.6 is an indole group, NCH.sub.3 C(.dbd.NH)NH.sub.2, SCH.sub.3, NH.sub.2, CH.sub.3, CO.sub.2 H, CONH.sub.2, or NHC(.dbd.NH)NH.sub.2, provided that when n=2 and R.sub.2 is H or M, R.sub.6 is not CH.sub.3 ;
- (CH.sub.2).sub.n CHNH.sub.2 CO.sub.2 H, wherein n=1-8;
- CH(CO.sub.2 H)NHCONH.sub.2 ;
- or,
- C.sub.5 H.sub.4 N;
- and
- wherein R.sub.2 is H, CH.sub.3, (CH.sub.2).sub.n CH.sub.3 wherein n=1-8, (CH.sub.2).sub.x O(CH.sub.2).sub.y CH.sub.3 or (CH.sub.2).sub.x CO(CH.sub.2).sub.y CH.sub.3 wherein x+y=2-7, or M, wherein M is a metal counterion or a low molecular weight organic cation;
- or the first agent comprises at least one chemical compound having the formula:
- R.sub.7 --SO.sub.2 --OR.sub.8,
- wherein R.sub.7 is a lower alkyl, aryl, substituted lower alkyl, or substituted aryl;
- and
- R.sub.8 is a hydrogen atom, a metal counterion, or a low molecular weight organic cation;
- and during and/or following the introduction of the foreign DNA, the cell is contacted with a second agent, wherein the second agent comprises at least one sulfonated amino polysaccharide or wherein the second agent comprises at least one chemical compound having the formula:
- ##STR5## wherein R.sub.1 is:
- CHNH.sub.2 R.sub.3, wherein R.sub.3 is the side chain of a naturally occurring amino acid;
- C.sub.6 H.sub.4 R.sub.4, wherein R.sub.4 is H, CH.sub.3, (CH.sub.2).sub.n CH.sub.3, NH.sub.2, COCH.sub.3, CO(CH.sub.2).sub.n CH.sub.3, C(CH.sub.3).sub.3, CH(CH.sub.3).sub.2, (CH.sub.2).sub.n CH(CH.sub.3).sub.2, (CH.sub.2).sub.n COCH.sub.3, OCH.sub.3, or O(CH.sub.2).sub.n CH.sub.3, wherein n=1-3;
- CHNH.sub.2 (CH.sub.2).sub.n R.sub.5, wherein n=1-7 and R.sub.5 is CH.sub.3, OH, CONH.sub.2, C.sub.6 H.sub.4 OH, or CONHNH.sub.2 ;
- (CH.sub.2).sub.n R.sub.6, wherein n=1-9 and R.sub.6 is an indole group, NCH.sub.3 C(.dbd.NH)NH.sub.2, SCH.sub.3, NH.sub.2, CH.sub.3, CO.sub.2 H, CONH.sub.2, or NHC(.dbd.NH)NH.sub.2, provided that when n=2 and R.sub.2 is H or M, R.sub.6 is not CH.sub.3 ;
- (CH.sub.2).sub.n CHNH.sub.2 CO.sub.2 H, wherein n=1-8;
- CH(CO.sub.2 H)NHCONH.sub.2 ;
- or,
- C.sub.5 H.sub.4 N;
- and
- wherein R.sub.2 is H, CH.sub.3, (CH.sub.2).sub.n CH.sub.3 wherein n=1-8, (CH.sub.2).sub.x O(CH.sub.2).sub.y CH.sub.3 or (CH.sub.2).sub.x CO(CH.sub.2).sub.y CH.sub.3 wherein x+y=2-7, or M, wherein M is a metal counterion or a low molecular weight organic cation;
- or the second agent comprises at least one chemical compound having the formula:
- R.sub.7 --SO.sub.2 --OR.sub.8,
- wherein R.sub.7 is a lower alkyl, aryl, substituted lower alkyl, or substituted aryl;
- and
- R.sub.8 is a hydrogen, a metal counterion, or a low molecular weight organic cation;
- and
- wherein the first agent is one that has a value for X that is greater than 25 when X is calculated according to the formula:
- ##EQU7## and wherein the second agent is one that has a value of G.sub.7 or G.sub.14 that is greater than 25, wherein G.sub.7 or G.sub.14 is calculated according to the formula:
- ##EQU8## wherein for both X or G.sub.7 or G.sub.14, "A" is the amount of the protein encoded by the foreign gene expressed in a first cell that is contacted with the first and the second agent, and "C" is the amount of protein expressed in a second cell that is not contacted with the first or the second agent.
A method of enhancing the transient expression of a foreign gene in a eukaryotic cell in vitro comprising:
- introducing into the cell a molecule of foreign DNA that encodes a protein in a form capable of being expressed in the cell;
- and,
- contacting the cell before, during, or after introducing the DNA with a transient expression enhancing agent;
- wherein the transient expression enhancing agent comprises:
- a compound selected from the group consisting of 3-methyl-L-histidine, .alpha.-ketoglutaric acid, 9-alanine, carnosine, citrulline, creatine, glutathione, hippuric acid, homoserine, N-carbamyl aspartic acid, N-formyl-L-methionine, ornithine, N-(4-aminobenzyl)-L-glutamic diethylester, ethyl-4-acetylbutyrate, adrenaline, methylcobalamin, benzoic acid, benzoate buffer, 4-ethylbenzoic acid and a sulfonated N-acetylated amino polysaccharide, disaccharide monomeric units derived from Type C chondroitin sulfate, polymannose, mannose;
- or
- a sulfonic acid derivative having the formula:
- R.sub.7 --SO.sub.2 --OR.sub.8
- wherein R.sub.7 is a lower alkyl, aryl, substituted lower alkyl, aryl, substituted lower alkyl, or substituted aryl, and R.sub.8 is a hydrogen, a metal counterion, or a low molecular weight organic cation;
- or
- benzoic acid and 4-ethylbenzoic acid;
- or
- benzoic acid and 4-ethylbenzoic acid and chondroitin sulfate;
- or
- benzoic acid and L-glutamine;
- or
- benzoate buffer and chondroitin sulfate;
- or
- benzoate buffer and glutamic acid;
- or
- lipoic acid and chondroitin sulfate;
- or
- benzoate buffer, chondroitin sulfate, and L-glutamine;
- or
- chondroitin sulfate and L-glutamine;
- or
- butyrate buffer and L-glutamine;
- or
- a mixture comprising glutathione, methionine, glycine, .alpha.-amino-n-butyric acid, taurine, phenylalanine, benzoate buffer, and alanine.
Dependencies are inferred from the claim text.